• contact BIO

    brought to you by
    Biotechnology Industry Organization
    1201 Maryland Ave., SW
    Washington, DC 20024
    202.962.9200
    www.bio.org

    terms of use
    privacy policy
  • Categories

  • Twitter Updates

Specter Proposes Cures Acceleration Network

A two-time cancer survivor and a perennial Republican swing voter, Senator Arlen Specter (R-PA), urged the creation of the Cures Acceleration Network, a new agency to provide grants to help biotech companies develop new treatments, reports Reuters and The Boston Globe:

I believe that we can live not only longer lives, but healthier lives, by harnessing [...]

PAN and Others Request Action from Congress

The Parkinson’s Action Network sent this to us for our blog:
The Parkinson’s Action Network and RetireSafe, along with 58 other organizations sent a letter to Congress urging them to take action on the SBIR Reauthorization Act this Congressional session. The Parkinson’s Action Network recognizes the unique needs of small biotechnology companies and that shrinking the [...]

SBIR, Patent Baristas and Seeking Cures

Welcome Back Senators! We hope you enjoyed your recess.
There is buzz that SBIR may make it on to the Senate calendar this session, but we do not have a definite date just yet. Stay tuned!
This act will increase access to early-stage funding for treatments and cures for debilitating diseases. With so many new treatments [...]

Conversation with Michael Weingarten

The feature story in the July 2008 Oncology Business Review is “On-Conversation with Michael Weingarten, Director, Small Business Innovation Research program (SBIR), Office of the Director, National Cancer Institute.”
NOTE: We have highlighted a few of Weingarten’s answers below. Please follow the links for the full interview.
OBR: HOW HAS THIS PROGRAM BEEN ADMINISTERED TO THIS [...]

Chat with John Risner, President of the Children’s Tumor Foundation

Hopes and Cures spokes to John Risner, President of The Children’s Tumor Foundation about the group’s work, in particular about funding for research.  CTF is a non-profit 501(c) (3) medical foundation, dedicated to improving the health and well being of individuals and families affected by the neurofibromatosis (NF).
 
ABOUT NF
Neurofibromatosis (NF) is the term for [...]

Alzheimer’s Drug Discovery Foundation

 

 
Alzheimer’s Drug Discovery Foundation
A new way to look at funding
The Alzheimer’s Drug Discovery Foundation (ADDF) raises money and awards grants to academic and biotechnology industry scientists who are conducting drug discovery research for Alzheimer’s Disease, related dementias and cognitive aging.
The way research is funded is evolving and by employing a venture capital model, [...]

Conversation with the American Autoimmune Related Disease Association

We chatted with Virginia Ladd, President and Executive Director of the American Autoimmune Related Disease Association.
What is the scope of your work?
There are over 100 types of autoimmune related diseases, including lupus, type I diabetes, scleroderma, celiac, multiple sclerosis, Crohn’s disease, autoimmune hepatitis, rheumatoid arthritis, Graves’ disease, and Sjogren’s syndrome. The NIH estimates that 23.5 [...]

In which we respond to California Biotech Law Blog

California Biotech Law Blog posted a summary of recent House hearings on reauthorizing the Small Business Innovation Research Program (SBIR).

In the world of biotechnology, the principle at stake is the United States’s claim to be an innovation engine in the global economy. Our members and their scientists are developing disease treatments and cures at a rapid rate, but because these cutting-edge treatments are so new, it takes 10-15 years before they reach the market. In the meantime, they thrive on traditional venture capital and the government’s version of VC: the SBIR program.

If Congress wants to perpetuate the image – and reality – of the US as the center of innovation, they must adapt the criteria for SBIR grants to match the reality for these budding treatments and burgeoning companies.

5 Questions with SSTI’s Vice President Mark Skinner

What is State Science & Technology Institute (SSTI)?
It is a national nonprofit organization based outside of Columbus, OH, that is dedicated to leading, supporting, and strengthening public-private efforts to improve regional economies through science, technology and innovation.   Part of SSTI’s mission is to serve as a neutral convener for discussion and advancement of key issues [...]

Conversation with the Cystic Fibrosis Foundation

 
The Cystic Fibrosis Foundation is the leading organization in the United States devoted to curing and controlling cystic fibrosis. We spoke with Mary Dwight about her organization and the important work they do.
 Can you tell us a bit about CFF’s purpose?  The Cystic Fibrosis Foundation is the leader in developing drugs to treat and [...]